STAP Papers Retracted

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

By | July 2, 2014

HARUKO OBOKATAAfter months of failed replication attempts, institutional investigations, findings of research misconduct, and several calls for retractions, RIKEN’s Haruko Obokata and her colleagues today (July 2) pulled both of their stimulus-triggered acquisition of pluripotency (STAP) studies. Also retracted was Austin Smith’s News and Views article, which accompanied the two STAP papers when they were published in Nature in January. Smith, a stem-cell researcher from the University of Cambridge, wrote in a Nature notice that his comments were “based on the accuracy and reproducibility of [Obokata and her colleagues’] data.”

In an editorial published today, the journal’s editors said they had verified that STAP was independently replicated in the coauthors’ labs before publishing the studies, and that reviewers of the work “could not have detected the problems that fatally undermined the papers.” Rather, the editors said, Nature was misled by the studies’ authors (specifically, in their contributions statements). “The referees’ rigorous reports quite rightly took on trust what was presented in the papers,” the editors wrote.

“In short: although editors and referees could not have detected the fatal faults in this work, the episode has further highlighted flaws in Nature’s procedures and in the procedures of institutions that publish with us,” the journal’s staff concluded.


Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Inside a Lab Mouse’s High-Fat Diet
  2. Antidepressant Exerts Epigenetic Changes
  3. How Gastric Bypass Can Kill Sugar Cravings
  4. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

Life Technologies